Involvement of Adenosine A1 and A2A Receptors in the Motor Effects of Caffeine after its Acute and Chronic Administration
The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
The involvement of adenosine A(1) and A(2A) receptors in the motor effects of caffeine is still a matter of debate. In the present study, counteraction of the motor-depressant effects of the selective A(1) receptor agonist CPA and the A(2A) receptor agonist CGS 21680 by caffeine, the selective A(1) receptor antagonist CPT, and the A(2A) receptor antagonist MSX-3 was compared. CPT and MSX-3 produced motor activation at the same doses that selectively counteracted motor depression induced by CPA and CGS 21680, respectively. Caffeine also counteracted motor depression induced by CPA and CGS 21680 at doses that produced motor activation. However, caffeine was less effective than CPT at counteracting CPA and even less effective than MSX-3 at counteracting CGS 21680. On the other hand, when administered alone in habituated animals, caffeine produced stronger motor activation than CPT or MSX-3. An additive effect on motor activation was obtained when CPT and MSX-3 were coadministered. Altogether, these results suggest that the motor-activating effects of acutely administered caffeine in rats involve the central blockade of both A(1) and A(2A) receptors. Chronic exposure to caffeine in the drinking water (1.0 mg/ml) resulted in tolerance to the motor effects of an acute administration of caffeine, lack of tolerance to amphetamine, apparent tolerance to MSX-3 (shift to the left of its 'bell-shaped' dose-response curve), and true cross-tolerance to CPT. The present results suggest that…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, functional interactions between A2A receptors and dopaminergic signaling pathways suggest that caffeine’s central stimulant effects likely arise from the broader disinhibition of a multi-neurotransmitter network, driven by concurrent antagonism of A1 and A2A receptors, rather than from blockade of a single receptor pathway alone [37,38].”
From Pre-Exercise Caffeine as a Modulator of Exercise-Induced Acute Cardiometabolic Responses: A Narrative Review (2026) · cites this paper as [38]
Citations
Cites
A psychomotor stimulant theory of addiction.
Wise, R. A., & Bozarth, M. A. (1987) · Psychological Review · doi:10.1037/0033-295x.94.4.469 · Cited by 2,747
Fredholm, B. B., Bättig, K., Holmén, J., Nehlig, A., & Zvartau, E. E. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01396-6 · Cited by 2,624
International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors
Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., Klotz, K.-N., & Linden, J. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01511-4 · Cited by 2,585
Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor
Ledent, C., Vaugeois, J.-M., Schiffmann, S. N., Pedrazzini, T., Yacoubi, M. E., Vanderhaeghen, J.-J., Costentin, J., Heath, J. K., Vassart, G., & Parmentier, M. (1997) · Nature · doi:10.1038/41771 · Cited by 918
Pontieri, F. E., Tanda, G., & Di Chiara, G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.12304 · Cited by 868
Adenosine–dopamine receptor–receptor interactions as an integrative mechanism in the basal ganglia
Ferré, S., Fuxe, K., B. Fredholm, B., Morelli, M., & Popoli, P. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01096-5 · Cited by 824
Self-citationAdenosine receptors and behavioral actions of methylxanthines.
Snyder, S. H., Katims, J. J., Annau, Z., Bruns, R. F., & Daly, J. W. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.5.3260 · Cited by 694
(1962) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1962.tb27008.x · Cited by 586
Ferre, S., von Euler, G., Johansson, B., Fredholm, B. B., & Fuxe, K. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.16.7238 · Cited by 552
Self-citationHillion, J., Canals, M., Torvinen, M., Casadó, V., Scott, R., Terasmaa, A., Hansson, A., Watson, S., Olah, M. E., Mallol, J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107731200 · Cited by 500
Self-citation
Cited by
Items 101–190 of 190
Maternal caffeine intake impairs MK-801-induced hyperlocomotion in young rats
da Silva, R. S., Hoffman, A., Souza, D. O., Lara, D. R., & Bonan, C. D. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.01.001 · Cited by 24
Research requirements for operational decision-making using models of fatigue and performance.
Friedl, K. E., Mallis, M. M., Ahlers, S. T., Popkin, S., & Larkin, W. D. (2004) · PubMed · Cited by 28
Tronci, E., Simola, N., Carta, A. R., Luca, M. A. D., & Morelli, M. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03943.x · Cited by 27
Blockade of adenosine A2A receptor counteracts neuropeptide-S-induced hyperlocomotion in mice
Boeck, C. R., Martinello, C., de Castro, A. A., Moretti, M., Casagrande, T. D. S., Guerrini, R., Calò, G., & Gavioli, E. C. (2009) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-009-0480-2 · Cited by 22
Fiebich, B. L., Candelario‐Jalil, E., Mantovani, M., HEINZMANN, M., Akundi, R. S., HULL, M., Knörle, R., Schnierle, P., Finkenzeller, G., & Aicher, B. (2006) · Pharmacological Research · doi:10.1016/j.phrs.2006.02.002 · Cited by 22
Spatial Regulation Control of Oxygen Metabolic Consumption in Mouse Brain
Zhou, L., Li, X., & Su, B. (2022) · Advanced Science · doi:10.1002/advs.202204468 · Cited by 22
Assessment of the Drug–Drug Interaction Potential Between Theacrine and Caffeine in Humans
He, H., Ma, D., Crone, L. B., Butawan, M. B., Meibohm, B., Bloomer, R. J., & Yates, C. R. (2017) · Journal of Caffeine Research · doi:10.1089/jcr.2017.0006 · Cited by 21
Modulatory effects of caffeine on oxidative stress and anxiety-like behavior in ovariectomized rats
Caravan, I., Sevastre-Berghian, A., Moldovan, R., Decea, N., Orăsan, R., & Filip, G. A. (2016) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2015-0502 · Cited by 21
The role of nucleus accumbens adenosine–opioid interaction in mediating palatable food intake
Pritchett, C. E., Pardee, A. L., McGuirk, S. R., & Will, M. J. (2009) · Brain Research · doi:10.1016/j.brainres.2009.09.115 · Cited by 20
Paraxanthine: Connecting Caffeine to Nitric Oxide Neurotransmission
Ferré, S., Orrù, M., & Guitart, X. (2013) · Journal of Caffeine Research · doi:10.1089/jcr.2013.0006 · Cited by 21
Self-citationMoghadamnia, A. A., Zargar-Nattaj, S. S., Tayyebi, P., Zangoori, V., Moghadamnia, Y., Roodgari, H., & Jorsaraei, S. G. A. (2011) · Psychology Research and Behavior Management · doi:10.2147/prbm.s15905 · Cited by 18
Mehta, A. K., Halder, S., Khanna, N., Tandon, O. P., & Sharma, K. K. (2013) · Nutritional Neuroscience · doi:10.1179/1476830512y.0000000051 · Cited by 18
Pardo, M., Paul, N. E., Collins‐Praino, L. E., Salamone, J. D., & Correa, M. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.173035 · Cited by 17
Puri, N., Mohey, V., Singh, M., Kaur, T., Pathak, D., Buttar, H. S., & Singh, A. P. (2016) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-015-1206-2 · Cited by 17
Serefko, A., Szopa, A., Właź, A., Wośko, S., Właź, P., & Poleszak, E. (2015) · Journal of Neural Transmission · doi:10.1007/s00702-015-1467-4 · Cited by 17
de Vaca, S. C., Kannan, P., Pan, Y., Jiang, N., Sun, Y., & Carr, K. D. (2007) · Brain Research · doi:10.1016/j.brainres.2007.01.035 · Cited by 18
Gliotransmission and adenosinergic modulation: insights from mammalian spinal motor networks
Acton, D. G., & Miles, G. B. (2017) · Journal of Neurophysiology · doi:10.1152/jn.00230.2017 · Cited by 18
Kroll, T., Elmenhorst, D., Weisshaupt, A., Beer, S., & Bauer, A. (2014) · Molecular Imaging and Biology · doi:10.1007/s11307-014-0729-0 · Cited by 16
Hanafy, A. S., Steinlein, P., Pitsch, J., Silva, M. H., Vana, N., Becker, A. J., Graham, M. E., Schoch, S., Lamprecht, A., & Dietrich, D. (2023) · Nature Communications · doi:10.1038/s41467-023-36070-6 · Cited by 17
Smith, K. M., Browne, S. E., Jayaraman, S., Bleickardt, C. J., Hodge, L. M., Lis, E. V., Yao, L., Rittle, S. L., Innocent, N., Mullins, D. E., et al. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.01.052 · Cited by 15
Caffeinated Alcoholic Beverages – An Emerging Trend in Alcohol Abuse
Hauser, S. R. (2013) · Journal of Addiction Research & Therapy · doi:10.4172/2155-6105.s4-012 · Cited by 20
Data-driven modeling of zebrafish behavioral response to acute caffeine administration
Burbano-L., D. A., & Porfiri, M. (2019) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2019.110054 · Cited by 15
Caffeine's Attenuation of Cocaine-Induced Dopamine Release by Inhibition of Adenosine
Malave, L. B., & Broderick, P. A. (2014) · Journal of Caffeine Research · doi:10.1089/jcr.2014.0004 · Cited by 14
Kosmowska, B., Ossowska, K., Głowacka, U., & Wardas, J. (2017) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12692 · Cited by 14
Lovin, L. M., Scarlett, K. R., Henke, A. N., Sims, J. L., & Brooks, B. W. (2023) · Environment International · doi:10.1016/j.envint.2023.107995 · Cited by 14
Schindler, C. W., Karcz‐Kubicha, M., Thorndike, E. B., Müller, C. E., Tella, S. R., Goldberg, S. R., & Ferré, S. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.11.010 · Cited by 13
Self-citationKhadrawy, Y. A., Sawie, H. G., Hosny, E. N., & Mourad, H. H. (2018) · Bulletin of the National Research Centre/Bulletin of the National Research Center · doi:10.1186/s42269-018-0034-1 · Cited by 15
Caffeine-induced Augmentation of Antidepressant Therapy
Kale, P. P., Addepalli, V., Bafna, P. A., & Prabhavalkar, K. S. (2010) · Journal of Experimental & Clinical Medicine · doi:10.1016/j.jecm.2010.09.001 · Cited by 14
Cocaine Shifts the Estrus Cycle Out of Phase and Caffeine Restores It
Broderick, P. A., & Malave, L. B. (2014) · Journal of Caffeine Research · doi:10.1089/jcr.2014.0015 · Cited by 14
Behavioural and neurochemical characterization of the adenosine A2A receptor antagonist ST1535
Galluzzo, M., Pintor, A., Pèzzola, A., Grieco, R., Borsini, F., & Popoli, P. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.10.057 · Cited by 13
Self-citationValenti, O., Zambon, A., & Boehm, S. (2021) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyab049 · Cited by 10
Preclinical jockeying on the translational track of adenosine A2A receptors
Barkhoudarian, M. T., & Schwarzschild, M. A. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2010.12.022 · Cited by 12
Schulz, D. (2018) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000396 · Cited by 14
Ulenius, L., Adermark, L., Söderpalm, B., & Ericson, M. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.172795 · Cited by 12
The role of adenosine A1 receptors in the nucleus accumbens during morphine withdrawal
Demirkapu, M. J., Yananlı, H. R., Kaleli, M., Sakallı, H. E., Gören, M. Z., & Topkara, B. (2019) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13224 · Cited by 13
Coffee and Cardiovascular Health: A Review of Literature
Farraj, A., Akeredolu, T., Wijeyesekera, A., & Mills, C. E. (2024) · Nutrients · doi:10.3390/nu16244257 · Cited by 16
Silva, R. S. D., Richetti, S. K., Tonial, E. M., Bogo, M. R., & Bonan, C. D. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0577-0 · Cited by 11
Olopade, F. E., Femi-Akinlosotu, O. M., Adekanmbi, A. J., Ighogboja, O. O., & Shokunbi, M. T. (2021) · Journal of Caffeine and Adenosine Research · doi:10.1089/caff.2020.0017 · Cited by 11
Behavioural and Toxic Interaction Profile of Ketamine in Combination with Caffeine
Hsu, H., Mei, Y., Wu, C., Chiu, P., & Chen, H. (2009) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2009.00382.x · Cited by 11
Listos, J., Talarek, S., Listos, P., Orzelska‐Górka, J., Łupina, M., & Fidecka, S. (2015) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-015-1190-6 · Cited by 11
Uchiyama, H., Toda, A., Imoto, M., Nishimura, S., Kuroki, H., Soeda, S., Shimeno, H., Watanabe, S., & Eyanagi, R. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.11.069 · Cited by 11
Moghadamnia, A. A., Zangoori, V., Zargar-Nattaj, S. S., Tayebi, P., Moghadamnia, Y., & Jorsaraei, S. G. A. (2010) · Journal of Experimental Pharmacology · doi:10.2147/jep.s10645 · Cited by 10
Duroux, R., Agouridas, L., Renault, N., Bakali, J. E., Furman, C., Melnyk, P., & Yous, S. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.12.007 · Cited by 11
Effects of oral caffeine pretreatment on response to intravenous nicotine and cocaine.
Johnson, M. W., Strain, E. C., & Griffiths, R. R. (2010) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0020509 · Cited by 9
Herbet, M., Szopa, A., Serefko, A., Wośko, S., Gawrońska‐Grzywacz, M., Izdebska, M., Piątkowska‐Chmiel, I., Betiuk, P., Poleszak, E., & Dudka, J. (2018) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2018.02.021 · Cited by 11
Using caffeine as a chemical means to induce flow states
Reich, N., Mannino, M., & Kotler, S. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105577 · Cited by 9
Kaplan, G. B., Leite‐Morris, K. A., Klufas, M. A., & Fan, W. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.10.052 · Cited by 8
Bata-García, J. L., Tun-Cobá, L., Álvarez-Cervera, F. J., Villanueva-Toledo, J. R., Heredia-López, F. J., & Góngora-Alfaro, J. L. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2009.12.072 · Cited by 8
Effects of adenosine A2A receptor antagonists on cocaine-induced locomotion and cocaine seeking
Haynes, N. S., O’Neill, C. E., Hobson, B. D., & Bachtell, R. K. (2018) · Psychopharmacology · doi:10.1007/s00213-018-5097-z · Cited by 9
Integrative Biological, Cognitive and Affective Modeling of Caffeine Use on Stress
de Haan, R. E., Blankert, M., & Ziabari, S. S. M. (2019) · Advances in intelligent systems and computing · doi:10.1007/978-3-030-23887-2_9 · Cited by 7
Salamone, J. D., Correa, M., Randall, P. A., Nunes, E. J., Pardo, M., & López‐Cruz, L. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3903-5_23 · Cited by 10
Neurobiology of chronic caffeine use and withdrawal: Mechanisms, effects and implications
Lee, Y. Z., Chua, K. N., Voon, F., Tham, C. L., Ho, Y., & Lee, M. T. (2025) · Food and Chemical Toxicology · doi:10.1016/j.fct.2025.115817 · Cited by 7
de Carvalho, C. R., da Cruz, J. S., & Takahashi, R. N. (2012) · Journal of Caffeine Research · doi:10.1089/jcr.2012.0013 · Cited by 6
Edem, E. E., Okhonmina, U., Nebo, K. E., Akinluyi, E. T., Ikuelogbon, D. A., Fafure, A. A., Olabiyi, A. A., & Adedokun, M. A. (2022) · Neurotoxicity Research · doi:10.1007/s12640-022-00589-1 · Cited by 5
Dutra-Tavares, A. C., Ribeiro‐Carvalho, A., Nunes, F., Araújo, U. C., Bruno, V., Marcourakis, T., Filgueiras, C. C., Manhães, A. C., & Abreu‐Villaça, Y. (2023) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174423000077 · Cited by 5
Zawieja, E. E., Chmurzyńska, A., Anioła, J., Zawieja, B. E., & Cholewa, J. M. (2023) · Nutraceuticals · doi:10.3390/nutraceuticals3020022 · Cited by 4
Pollack, A. E., Dimitrov, K. D., & Drake, J. (2010) · Pharmacology · doi:10.1159/000315496 · Cited by 4
Olopade, F. E., & Shokunbi, M. T. (2017) · Journal of Caffeine and Adenosine Research · doi:10.1089/caff.2017.0010 · Cited by 4
Hines, R. M., Khumnark, M., Macphail, B., & Hines, D. J. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00983 · Cited by 8
Behavioral Pharmacology of Caffeine
Fenu, S., & Acquas, E. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-384937-3.00113-0 · Cited by 5
Caffeine in Parkinson's disease: Comment on its importance and the dose proposal
Kitagawa, M., Houzen, H., & Tashiro, K. (2012) · Movement Disorders · doi:10.1002/mds.24988 · Cited by 4
Ramerth, A., Chapple, B. E., Winter, J., & Moore, W. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168966 · Cited by 3
From Clinical to Basic Research: The Neuroprotective Effects and Mechanisms of Caffeine
Wang, L., & Wang, L. (2025) · Health and Metabolism · doi:10.53941/hm.2025.100008 · Cited by 6
What Is the Role of Adenosine Tone and Adenosine Receptors in Huntington’s Disease?
Blum, D., Chern, E. C., Domenici, M. R., Buée, L., Lin, C. Y., Ferré, S., & Popoli, P. (2018) · Springer eBooks · doi:10.1007/978-3-319-90808-3_12 · Cited by 5
Self-citationA Pattern of Adolescent Caffeine Consumption that Reduces Alcohol Withdrawal Severity
Pitchon, D. N., Zook, M., & Rhoads, D. E. (2013) · Journal of Caffeine Research · doi:10.1089/jcr.2013.0011 · Cited by 3
Effect of adenosine system in the action of oseltamivir on behavior in mice
Uchiyama, H., Hiromura, M., Shiratani, T., Kuroki, H., Honda, S., Kosako, K., Soeda, S., Inoue, K., & Toda, A. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.05.014 · Cited by 4
Substance Use and Addictive Disorders: Caffeine
Meredith, S. E., & Griffiths, R. R. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch73 · Cited by 3
Geng, H., Zhou, Z., Meng, L., Zhuang, M., & Zhao, Y. (2026) · Metabolites · doi:10.3390/metabo16070478 · Cited by 2
“…and dopaminergic signaling pathways suggest that caf-feine’s central stimulant effects likely arise from the broader disinhibition of a multi-neurotransmitter network, driven by concurrent antagonism of A1 and A2A receptors, rather than from blockade of a single receptor pathway alone [37,38].”
Caffeine, Adenosine A 1 Receptors, and Brain Cortex. Molecular Aspects
Cortés, A., Casadó-Anguera, V., Moreno, E., & Casadó, V. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800634-4.00074-3 · Cited by 6
Zhu, H., Bai, S., Ma, W., Qian, H., & Du, P. (2023) · Food & Function · doi:10.1039/d3fo03841f · Cited by 2
Penna, D. B. D. S., Costa, S. G., dos Santos‐Rodrigues, A., & Pandolfo, P. (2024) · Brain Research · doi:10.1016/j.brainres.2024.148937 · Cited by 2
Cadmium and Caffeine in Coexposure but Not Alone, in Low Doses, Modulate Aggression Behavior in Rats
Godinho, A. F., de Souza, R. P., Anselmo, F., & Silva, N. C. C. (2017) · Journal of Caffeine Research · doi:10.1089/jcr.2016.0016
Lin, Y.-S., Weibel, J., Landolt, H., Santini, F., Slawik, H. C., Borgwardt, S., Cajochen, C., & Reichert, C. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.19.440520 · Cited by 2
Vazquez-Matias, D. A., Henry, S., Guerrin, C. G. J., Prasad, K., Doorduin, J., & de Vries, E. F. J. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111540 · Cited by 1
Hu, Y., Zhang, B., Hu, Z., Liu, X., Li, X., & Dai, J. (2025) · Sensors · doi:10.3390/s25247552 · Cited by 1
Merkohitaj, O. (2023) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9967 · Cited by 1
Effects of long-term administration of caffeine in a mouse model for Alzheimer's disease
Schleif, W. S. (2005) · Digital Commons - University of South Florida (University of South Florida)
Uppers and downers: Understanding sleep regulation using small molecules in Drosophila
Nall, A. H. (2014) · ScholarlyCommons (University of Pennsylvania)
La cafeína en la enfermedad de Parkinson
Ferré, S. (2008) · Medicina Clínica · doi:10.1157/13129123
Self-citationPROGRAMA DE PÓS-GRADUAÇÃO EM BIOLOGIA CELULAR E MOLECULAR
Menezes, F. P. (2014)
da Costa, M. S., Porciúncula, L. O., & Alegre, P. (2008)
Antoniou, K. M., Papadopoulou‐Daifoti, Z., Hyphantis, T. N., Papathanasiou, G., Bekris, E., Μαρσέλος, Μ., Müller, C. E., Goldberg, S. R., & Ferré, S. (2005)
Self-citationPechlivano, D. M., Tchekalaro, J. D., Nenchovska, Z., & YAKIMOVA, K. S. (2015) · Pharmacologia · doi:10.5567/pharmacologia.2015.307.312
Papel do receptor B2 de cininas na terapia da neurodegeneração dopaminérgica em modelo animal
de Souza, H. D. N. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.46.2018.tde-12122018-113241
Taurine and dopamine-related effects of ethanol. An experimental study in rodents
Ulenius, L. (2019) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 1
Xanthines (Caffeine) and Nicotine
(2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-387-25733-0_11
Olopade, F. E., & Shokunbi, M. T. (2017) · Journal of Caffeine Research · doi:10.1089/jcr.2017.0010
Brockhoff, B. (2015) · NSUWorks (Nova Southeastern University)
BindingDB Entry 50002918: Antagonists of the adenosine A
BindingDB (2020) · UC San Diego · doi:10.7270/q2rf5xpz
Metadata
- Authors
- Karcz-Kubicha, M., Antoniou, K., Terasmaa, A., Quarta, D., Solinas, M., Justinova, Z., Pezzola, A., Reggio, R., Müller, C. E., Fuxe, K., Goldberg, S. R., Popoli, P., & Ferré, S.
- Affiliations
- National Institutes of Health (US)
- Karolinska Institutet (SE)
- Istituto Superiore di Sanità (IT)
- University of Bonn (DE)
- Corresponding author
- Ferré, Sergi
- ORCID
- Venue
- Neuropsychopharmacology
- Published
- 2003-01-20
- Volume
- 28
- Issue
- 7
- Pages
- 1281-1291
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2056124241
- Cited by
- 189
- References
- 60
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 4 · 2023: 8 · 2022: 3 · 2021: 5 · 2020: 1 · 2019: 8 · 2018: 14 · 2017: 7 · 2016: 6 · 2015: 10 · 2014: 12 · 2013: 7 · 2012: 8
- FWCI
- 5.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Health Sciences › Medicine › Pharmacology (medical) › Coffee research and impacts
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- caffeine, adenosine A1 receptor, adenosine A2A receptor, motor activation, caffeine tolerance, cross-tolerance, CPT, MSX-3, CPA, CGS 21680, receptor antagonists
- MeSH terms
- Adenosine, Amphetamine, Central Nervous System Stimulants, Animals, Behavior, Animal, Caffeine, Dose-Response Relationship, Drug, Drug Administration Schedule, Drug Interactions, Male, Motor Activity, Phenethylamines, Radioligand Assay, Theophylline, Time Factors, Triazines, Triazoles, Tritium, Xanthines, Rats, Sprague-Dawley, Receptors, Purinergic P1, Receptor, Adenosine A2A, Rats, Purinergic P1 Receptor Agonists, Purinergic P1 Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.